1. Home
  2. JRVR vs SGHT Comparison

JRVR vs SGHT Comparison

Compare JRVR & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • SGHT
  • Stock Information
  • Founded
  • JRVR 2002
  • SGHT 2011
  • Country
  • JRVR Bermuda
  • SGHT United States
  • Employees
  • JRVR N/A
  • SGHT N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • SGHT Medical Specialities
  • Sector
  • JRVR Finance
  • SGHT Health Care
  • Exchange
  • JRVR Nasdaq
  • SGHT Nasdaq
  • Market Cap
  • JRVR 255.2M
  • SGHT 222.3M
  • IPO Year
  • JRVR 2005
  • SGHT 2021
  • Fundamental
  • Price
  • JRVR $5.59
  • SGHT $3.44
  • Analyst Decision
  • JRVR Buy
  • SGHT Buy
  • Analyst Count
  • JRVR 4
  • SGHT 8
  • Target Price
  • JRVR $6.06
  • SGHT $4.01
  • AVG Volume (30 Days)
  • JRVR 230.9K
  • SGHT 164.1K
  • Earning Date
  • JRVR 08-04-2025
  • SGHT 07-31-2025
  • Dividend Yield
  • JRVR 0.73%
  • SGHT N/A
  • EPS Growth
  • JRVR N/A
  • SGHT N/A
  • EPS
  • JRVR N/A
  • SGHT N/A
  • Revenue
  • JRVR $678,788,000.00
  • SGHT $78,109,000.00
  • Revenue This Year
  • JRVR $1.95
  • SGHT N/A
  • Revenue Next Year
  • JRVR $6.80
  • SGHT $11.60
  • P/E Ratio
  • JRVR N/A
  • SGHT N/A
  • Revenue Growth
  • JRVR N/A
  • SGHT N/A
  • 52 Week Low
  • JRVR $3.00
  • SGHT $2.03
  • 52 Week High
  • JRVR $8.99
  • SGHT $8.45
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 44.70
  • SGHT 37.27
  • Support Level
  • JRVR $5.48
  • SGHT $3.36
  • Resistance Level
  • JRVR $5.73
  • SGHT $4.33
  • Average True Range (ATR)
  • JRVR 0.16
  • SGHT 0.26
  • MACD
  • JRVR -0.06
  • SGHT -0.13
  • Stochastic Oscillator
  • JRVR 12.39
  • SGHT 6.39

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Share on Social Networks: